Efficacy and Safety Study of PEX168 in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin

NCT02477969 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

587

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: PEX168(100µg)
DRUG: PEX168(200µg)
DRUG: Placebo
DRUG: Metformin

Sponsor

Jiangsu Hansoh Pharmaceutical Co., Ltd.